Kintara Therapeutics Announces Fiscal 2023 Second Quarter Financial Results and Provides Corporate Update

SAN DIEGO, Feb. 14, 2023 /PRNewswire/ — Kintara Therapeutics, Inc. (NASDAQ: KTRA) (“Kintara” or the “Company”), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced financial results for its fiscal second quarter ended December 31,…

Click here to view original post